The tirzepatide weight loss dose climbs in stages, roughly four weeks apart, from a starting 2.5 mg to a maximum of 15 mg. This is the standard titration for tirzepatide, sold as Mounjaro and Zepbound. Read it as clinical guidance, not a prescription. Your actual pace is set at your visit, and it is often slower than the table below.
Want the same framing for the medication itself? See how tirzepatide works and who it fits, or how we step up GLP-1 dosing week by week under supervision.
Holding a dose is not falling behind. It is the whole point of supervision. Here are the four situations where we press pause instead of pushing higher. Each one is something a weekly check-in catches and an auto-refill misses. When symptoms are the issue, we lean on the same playbook we use for slowing the dose ramp when side effects appear.
If GI symptoms from the last step-up are still with you, climbing again stacks a new wave on top of an old one. We hold until you have a clean, comfortable week.
A dose that is producing steady loss is doing its job. There is no clinical benefit to escalating past what is already working.
Travel, a stomach bug, a stressful stretch at work. We routinely delay a step-up by a week or two when the timing would set you up to feel awful.
If you are barely eating or drinking, more medication is the wrong move. We slow down and get your intake back on track first.
The maximum tirzepatide weight loss dose is 15 mg once weekly. But the ceiling is not the target. In the pivotal SURMOUNT-1 trial, patients on 5 mg, 10 mg, and 15 mg all lost meaningful weight, and the right dose for you is simply the lowest one that keeps the scale moving without making you miserable.
Have a question we didn't cover? See our full FAQ or call us — one of our team will actually answer.
How the dual GLP-1 + GIP shot works and who it fits.
7 min readWhat to expect at each dose and how we slow the ramp.
7 min readHow weekly check-ins keep dosing tuned to your body.
8 min read